US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 7.610
  • -0.320-4.04%
Close Apr 1 16:00 ET
  • 7.610
  • 0.0000.00%
Post 16:01 ET
771.31MMarket Cap-7.46P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 25, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
27.79M
29.21M
+1.42M
Beat Est.
--
--
+5.10%
EPS
-0.36
-0.69
-0.33
Miss Est.
+43.37%
-7.81%
-90.40%
Analyst Rating
Strong Buy

Mar 31, 2025

Day One Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 37.486M--
--2025/Q1-- / 31.345M--
Feb 25, 20252024/Q429.200M / 27.790M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 37.486M--
--2025/Q1-- / 31.345M--
Feb 25, 20252024/Q429.200M / 27.790M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--

Unlock Free Earnings Estimates

Day One Biopharmaceuticals Earnings Reports

  • Day One Biopharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 6 17:02 ET

  • Day One Biopharmaceuticals | 10-K: FY2024 Annual Report

    Feb 25 16:12 ET

  • Day One Biopharmaceuticals | 8-K: Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

    Feb 25 16:07 ET

  • Day One Biopharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 30, 2024 16:07 ET

    • Read more

    Market Insights

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    OKAY
    833230
    +29.96%
    CHANGFU CO.,LTD
    871396
    +24.59%
    Gansu Longshenrongfa Pharmaceutical Industry
    300534
    +20.05%
    4
    Tibet Duo Rui Pharmaceutical
    301075
    +20.02%
    5
    Chengda Pharmaceuticals
    301201
    +20.01%
    Log In for the Full List
    Unlock Now

    Investment Course

    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

    Reassessing Chinese Assets

    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

    Discussing

    FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
    🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
    FOMC Press Conference, March 19, 2025